Choksi Laboratories Limited
BSE: CHOKSILA
Prev Close
220.7
Open Price
220.7
Volume
511
Today Low / High
214.9 / 224.95
52 WK Low / High
60.21 / 236.7
Range
209 - 231
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 219.95, reflecting a change of -0.75 (-0.33983%). The expected target range on the BSE is 209 - 231. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Choksi Laboratories Limited Graph
Choksi Laboratories Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Choksi Laboratories Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 219.95, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 219.95 | 222.15 | 199.93 - 244.36 |
| 224.35 | 179.48 - 269.22 | ||
| 226.55 | 158.58 - 294.51 | ||
| Bearish Scenario | 219.95 | 217.75 | 195.98 - 239.53 |
| 215.55 | 172.44 - 258.66 | ||
| 213.35 | 149.35 - 277.36 |
Overview of Choksi Laboratories Limited
ISIN
INE493D01013
Industry
Specialty Business Services
Vol.Avg
16,986
Market Cap
1,564,745,659
Last Dividend
0
Official Website
IPO Date
2002-01-02
DCF Diff
49.67
DCF
180
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 41.78 Cr | 7.19 Cr | 34.59 Cr | 0.8280 | 0.00 Cr | 0.00 Cr | 4.80 Cr | 1.52 Cr | 2.16 | 11.30 Cr | 0.0365 |
| 2024-03-31 | 36.70 Cr | 3.72 Cr | 32.97 Cr | 0.8985 | 0.00 Cr | 1.05 Cr | 4.57 Cr | 1.11 Cr | 1.59 | 10.38 Cr | 0.0302 |
| 2023-03-31 | 34.44 Cr | 3.38 Cr | 31.06 Cr | 0.9018 | 0.00 Cr | 0.99 Cr | 4.80 Cr | 3.21 Cr | 4.61 | 12.73 Cr | 0.0932 |
| 2022-03-31 | 30.04 Cr | 2.83 Cr | 27.21 Cr | 0.9058 | 0.00 Cr | 0.75 Cr | 3.55 Cr | 0.21 Cr | 0.30 | 9.02 Cr | 0.0069 |
| 2021-03-31 | 25.69 Cr | 3.51 Cr | 22.18 Cr | 0.8634 | 0.00 Cr | 0.73 Cr | -0.42 Cr | -2.61 Cr | -3.74 | 4.59 Cr | -0.1015 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.61 Cr | 65.33 Cr | 41.73 Cr | 23.6048 Cr | 29.16 Cr | 28.54 Cr | 0.56 Cr | 47.13 Cr | 0.00 Cr | 0.00 Cr | 0.84 Cr | 23.8752 Cr |
| 2024-03-31 | 0.66 Cr | 61.95 Cr | 39.74 Cr | 22.2106 Cr | 30.87 Cr | 30.22 Cr | 0.36 Cr | 46.07 Cr | 0.23 Cr | 0.00 Cr | 0.25 Cr | 18.8476 Cr |
| 2023-03-31 | 0.34 Cr | 60.36 Cr | 39.26 Cr | 21.1084 Cr | 32.42 Cr | 32.08 Cr | 0.21 Cr | 44.75 Cr | 0.20 Cr | 0.00 Cr | 0.09 Cr | 12.5142 Cr |
| 2022-03-31 | 0.41 Cr | 64.42 Cr | 46.51 Cr | 17.9026 Cr | 37.29 Cr | 36.88 Cr | 0.25 Cr | 47.91 Cr | 0.24 Cr | 0.00 Cr | 0.40 Cr | 15.5235 Cr |
| 2021-03-31 | 0.31 Cr | 66.38 Cr | 48.63 Cr | 17.7462 Cr | 39.15 Cr | 38.84 Cr | 0.11 Cr | 50.54 Cr | 0.46 Cr | -0.58 Cr | 0.35 Cr | 16.2201 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 11.7780 Cr | -7.6050 Cr | -4.2176 Cr | 4.0911 Cr | -0.0446 Cr | 0.6123 Cr | -7.4393 Cr | 2.1533 Cr | -1.0508 Cr | 0.0000 Cr | -0.1934 Cr |
| 2024-03-31 | 8.7103 Cr | -6.8125 Cr | -4.5837 Cr | 1.5755 Cr | 0.3194 Cr | 0.6569 Cr | -7.0947 Cr | 1.1098 Cr | -1.1133 Cr | 0.0000 Cr | -0.1547 Cr |
| 2023-03-31 | 8.2538 Cr | -0.7084 Cr | -7.6149 Cr | 4.1031 Cr | -0.0696 Cr | 0.3375 Cr | -4.1507 Cr | 3.7214 Cr | -4.4073 Cr | 0.0000 Cr | 0.0414 Cr |
| 2022-03-31 | 7.8774 Cr | -2.7088 Cr | -5.0676 Cr | 5.0148 Cr | 0.1010 Cr | 0.4071 Cr | -2.8626 Cr | 0.3670 Cr | -1.4492 Cr | 0.0000 Cr | -0.1384 Cr |
| 2021-03-31 | 5.8984 Cr | -7.6469 Cr | 1.6291 Cr | -2.1987 Cr | -0.1194 Cr | 0.3061 Cr | -8.0971 Cr | -2.8081 Cr | 4.7267 Cr | 0.0000 Cr | 0.0650 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 11.40 Cr | 1.65 Cr | 9.75 Cr | 0.8553 | 1.86 Cr | 0.92 Cr | 1.31 | 3.55 Cr | 0.0808 |
| 2024-12-31 | 10.38 Cr | 1.96 Cr | 8.43 Cr | 0.8116 | 0.87 Cr | 0.11 Cr | 0.15 | 2.55 Cr | 0.0102 |
| 2024-09-30 | 9.26 Cr | 1.55 Cr | 7.71 Cr | 0.8328 | 0.74 Cr | 0.08 Cr | 0.11 | 2.37 Cr | 0.0082 |
| 2024-06-30 | 10.74 Cr | 7.74 Cr | 3.00 Cr | 0.2790 | 1.33 Cr | 0.42 Cr | 0.60 | 2.84 Cr | 0.0392 |
| 2024-03-31 | 11.18 Cr | 7.43 Cr | 3.76 Cr | 0.3359 | 2.06 Cr | 0.68 Cr | 0.98 | 3.55 Cr | 0.0610 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.61 Cr | 0.12 Cr | 0.73 Cr | 11.27 Cr | 0.56 Cr | 16.32 Cr | 47.13 Cr | 65.33 Cr | 41.73 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 0.22 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -23.01 Cr |
| 2024-09-30 | 0.22 Cr | 0.10 Cr | 0.32 Cr | 10.51 Cr | 0.65 Cr | 15.76 Cr | 47.00 Cr | 64.01 Cr | 40.99 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 0.66 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -22.21 Cr |
| 2024-03-31 | 0.66 Cr | 0.43 Cr | 0.66 Cr | 10.52 Cr | 0.36 Cr | 14.57 Cr | 46.07 Cr | 61.95 Cr | 39.74 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 0.11 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 0.08 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 0.42 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 0.68 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 0.06 Cr | 0.06 Cr | 0.00 Cr | 0.00 Cr | -9.19 Cr | 0.06 Cr | 9.26 Cr | 0.00 Cr | 0.06 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Specialty Business Services
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| BLS International Services Limited | BLS | ₹368.95 | ₹151,911,841,950.00 | ₹859,710.00 |
| Sundaram Finance Holdings Limited | SUNDARMHLD | ₹495.50 | ₹110,052,532,000.00 | ₹146,991.00 |
| CMS Info Systems Limited | CMSINFO | ₹440.05 | ₹72,376,136,827.00 | ₹177,862.00 |
| PDS Limited | PDSL | ₹326.75 | ₹46,186,112,500.00 | ₹55,401.00 |
Key Executives
Gender: male
Year Born:
Gender: male
Year Born: 1955
Gender: male
Year Born: 1979
Gender: female
Year Born: 1976
Gender: female
Year Born: 1956
FAQs about Choksi Laboratories Limited
The CEO is Sunil Kumar Choksi.
The current price is ₹224.65.
The range is ₹60.21-236.7.
The market capitalization is ₹156.47 crores.
The P/E ratio is 104.02.
The company operates in the Industrials sector.
Overview of Choksi Laboratories Limited (ISIN: INE493D01013) is a leading Specialty Business Services in India. With a market capitalization of ₹156.47 crores and an average daily volume of 16,986 shares, it operates in the Specialty Business Services. The company last declared a dividend of ₹0.